Pilot Study of Safety and Performance of a Mixture of Calcium Phosphate Granules Combined with Cellulosic-Derived Gel after Tunnel Filling Created during Surgical Treatment of Femoral Head Aseptic Osteonecrosis

摘要:

文章预览

The biomaterial studied here is a composite associating a mineral phase of an intimate nanoscale melting of hydroxyapatite and beta tri calcium phosphate and an aqueous phase containing a synthetic polymer derived from cellulose HPMC (hydroxyl propyl methyl cellulose), marketed under name MBCP Gel (FDA approval, Biomatlante manufacturer). The present exploratory study aim was to study the safety of MBCP-gel, and to determine in the osseous healthy area the performance of MBCP gel. We expected to prove bone ingrowth into the osseous cavities created during drilling biopsy of the aseptic osteonecrosis of femoral head. The current results obtained in the first two patients with 1 year follow up demonstrate the resorption and bone ingrowth with trabecular bone architecture in the hole created into the femoral neck.

信息:

期刊:

主题:

编辑:

Guy Daculsi and Pierre Layrolle

页数:

1295-1298

引用:

T. Fabre et al., "Pilot Study of Safety and Performance of a Mixture of Calcium Phosphate Granules Combined with Cellulosic-Derived Gel after Tunnel Filling Created during Surgical Treatment of Femoral Head Aseptic Osteonecrosis", Key Engineering Materials, Vols. 361-363, pp. 1295-1298, 2008

上线时间:

November 2007

输出:

价格:

$38.00

[1] Mainard D. Monographie du GEST (2005), www. maitrise-orthop. com/gesto.

[2] Daculsi G., Weiss P., Bouler J.M., Gauthier O., Aguado E. (1999) Bone, 25: 59-61.

[3] Gauthier O, Bouler Jm, Aguado E, Legeros R, Pilet P, Daculsi G. J Of Mater Sc : Mat In Med, 1999, 10: 199-204.

DOI: https://doi.org/10.1023/a:1008949910440

[4] Gauthier O, Bouler Jm, Weiss P, Bosco J, Daculsi G, Aguado E. J Biomed Mater Res, 1999, 47(1) : 28-35.

[5] Gauthier O., Bouler J.M., Weiss P., Bosco J., Aguado E. And Daculsi G. Bone. 1999 Aug; 25(2 Suppl): 71s-74s.

[6] Niwa S, LeGeros RZ (2002). Tissue Engineering and Biodegradable Equivalents. Scientific and Clinical Applications. Marcel Dekker, New York, pp.385-400.

[7] Le Guehennec L, Layrolle P, Daculsi G. Eur Cell Mater. 2004 Sep 13; 8: 1-11.

[8] Khairoun I, LeGeros RZ, Daculsi G, Bouler JM, Guicheux J, Gauthier O (2004). Provisional patent no. 11/054, 623.

[9] Weiss P, Layrolle P, Clergeau LP, Enckel B, Pilet P, Amouriq Y, Daculsi G, Giumelli B. (2007) Biomaterials. Apr 10; 28: 3295-305.

DOI: https://doi.org/10.1016/j.biomaterials.2007.04.006